Skip to main content
Circa Group AS logo

Circa Group AS — Investor Relations & Filings

Ticker · CIRCA ISIN · NO0010917594 LEI · 549300TYMT7PQV920R92 OL Manufacturing
Filings indexed 376 across all filing types
Latest filing 2021-02-17 Capital/Financing Update
Country NO Norway
Listing OL CIRCA

About Circa Group AS

https://circa-group.com/

Circa Group AS is a renewable chemicals company that develops and commercializes bio-based products. It utilizes a proprietary thermochemical process, Furacell™, to convert non-food, waste cellulosic biomass into advanced biochemicals. The company's portfolio is centered on the platform chemical levoglucosenone (LGO) and its derivatives, most notably the bio-based solvent Cyrene™. Cyrene™ is designed as a safer, more sustainable alternative to traditional, fossil-derived polar aprotic solvents like NMP. Circa aims to produce these biochemicals at an industrial scale, serving various markets, including pharmaceuticals, agrochemicals, and specialty polymers, that are transitioning to greener chemistry. The company is scaling up its manufacturing capabilities through its ReSolute plant project.

Recent filings

Filing Released Lang Actions
Circa Group AS: Contemplated private placement and listing on Euronext Growth
Capital/Financing Update Classification · 98% confidence The document explicitly announces a 'contemplated private placement and listing on Euronext Growth' for Circa Group AS. It details the offering structure (Primary Offering, Greenshoe Offering), the price per share (NOK 16.75), the intended use of proceeds (funding the ReSolute plant), and the involvement of financial managers (Pareto Securities AS, SpareBank 1 Markets AS). This content is characteristic of an announcement related to raising capital through the issuance of new shares, which aligns directly with the definition of 'Capital/Financing Update' (CAP). Although it involves a listing, the primary focus is the capital raise (Private Placement). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it describes a specific financing event.
2021-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.